Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.
about
New imaging approaches to phaeochromocytomas and paragangliomas.Phaeochromocytoma: a catecholamine and oxidative stress disorder.Usefulness of [18F]-DA and [18F]-DOPA for PET imaging in a mouse model of pheochromocytomaCurrent and future anatomical and functional imaging approaches to pheochromocytoma and paraganglioma.The norepinephrine transporter and pheochromocytoma.Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomasDifferential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma.Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene.Development of differential diagnosis for benign and malignant pheochromocytomas.Laparoscopic adrenalectomy for pheochromocytoma-does size matter? A single surgeon comparative study.Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma.Anesthetic considerations on adrenal gland surgery.The antidepressants maprotiline and fluoxetine have potent selective antiproliferative effects against Burkitt lymphoma independently of the norepinephrine and serotonin transporters.Neuropeptide Y expression in phaeochromocytomas: relative absence in tumours from patients with von Hippel-Lindau syndrome.The Author's Reply: inappropriate adrenoreceptor blockade prior to pheochromocytoma removal - 'A timely reappraisal'.Metabologenomics of Phaeochromocytoma and Paraganglioma: An Integrated Approach for Personalised Biochemical and Genetic Testing.Functional Imaging of Paragangliomas with an Emphasis on Von Hippel-Lindau-Associated Disease: A Mini Review.
P2860
Q34255457-358B0C0D-7318-4BB8-8BFB-E16AC78C9B27Q36149357-D2D70BCE-6182-4DEC-8CB3-892975BCF8DBQ36463116-CC860E38-63D1-49AA-9B05-85FF0BB57E0DQ36467134-90307A31-DBD9-48AA-A006-22377BF0667DQ36652797-246C5283-DA8B-46AB-A2BE-95D022422F2BQ36730594-81B2680F-0C82-4A3A-9BD5-8F2D81DDA130Q36976973-B16E574C-0475-4889-A047-48D22549BF4AQ37061292-B0504BA9-FD25-4F5C-8594-DE0A747ACCDFQ37225700-6EC1CC9D-5660-4FAE-A754-DA02A39338F0Q37351791-FF7507B5-57F0-4B83-A504-F3E73A8E35F2Q37482780-F38B1C2E-DCDD-458E-A713-72AA08D11409Q38264911-50267FE6-E48E-4A36-91D5-116174F3751EQ39742088-1CEA8BC0-1CB3-4AC7-BA4A-C8833E811633Q41442881-4C6C3614-FCF9-4447-BB7F-0C3C62AECF0BQ42365052-0D3EC459-5E30-4203-B0C6-476B321D7194Q49174438-E6AAAED7-1DC7-4B19-87ED-53383C3A7C27Q54612247-1AD8C9E0-7C71-4C5E-9C31-6AB8C0F3B4E6
P2860
Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Different expression of catech ...... le endocrine neoplasia type 2.
@ast
Different expression of catech ...... le endocrine neoplasia type 2.
@en
type
label
Different expression of catech ...... le endocrine neoplasia type 2.
@ast
Different expression of catech ...... le endocrine neoplasia type 2.
@en
prefLabel
Different expression of catech ...... le endocrine neoplasia type 2.
@ast
Different expression of catech ...... le endocrine neoplasia type 2.
@en
P2093
P2860
P356
P1476
Different expression of catech ...... le endocrine neoplasia type 2.
@en
P2093
Abdel G Elkahloun
David S Goldstein
Frederieke M Brouwers
Graeme Eisenhofer
Macclellan M Walther
Robert A Worrell
Susannah Cleary
Thanh-Truc Huynh
P2860
P304
P356
10.1530/EJE.1.01987
P577
2005-10-01T00:00:00Z